[ad_1] MLTX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Nov. 25, 2025 /PRNewswire/ — MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company, has been hit with a securities fraud class action lawsuit after […]

[ad_1] SAN FRANCISCO, Nov. 25, 2025 /PRNewswire/ — Synopsys, Inc. (NASDAQ: SNPS), a leading electronic design automation (EDA) company, is facing a significant leadership shakeup and escalating legal pressure, highlighted by the recent departure of […]

[ad_1] SAN FRANCISCO, Nov. 19, 2025 /PRNewswire/ — On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its […]

[ad_1] SAN FRANCISCO, Nov. 18, 2025 /PRNewswire/ — On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 […]

[ad_1] MLTX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Nov. 18, 2025 /PRNewswire/ — A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after […]